Dr. Cope previously worked at Sage Therapeutics as an in vivo pharmacology scientist II for small molecule drug candidates, and participated on a multi-disciplinary team for Pre-IND meetings with the US Food and Drug Administration (FDA).

Prior to Sage Therapeutics, he also worked for the MODEL-AD Center at the University of Pittsburgh Aging Institute developing novel mouse models and biomarkers for the study of neurodegeneration.

Zackary is published in the fields of cognitive neurobiology, aging, Alzheimers/dementia, behavioral health, and addiction, among others.

After living and working in the Appalachian Mountains and on both coasts, Zackary is happy to make his home in Pittsburgh. Zackary grew up near the Great Smoky Mountains National Park and hopes to see all the US National Parks in his lifetime. He enjoys a number of hobbies, especially anything outdoors like hiking, biking, birding, and gardening. He is also a cook and baker who aspires to travel and eat his way through all the great world cuisines.

Alethea Wieland, CRS President and Founder, remarks, “Zackary has a well-rounded background in pre-clinical and translational science in several of our key therapeutic areas and he is ready for the challenges of clinical trials.”

David Link, MBA, CRS CEO and Chief Quality and Regulatory Officer, adds, “Dr. Cope has an enviable background for our clients and management consulting practice group, and we know he will excel in a fast-paced environment typical of the trials industry.”

About Clinical Research Strategies, LLC:

CRS is a specialty clinical CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up, mid-sized, and large life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.

Indications represented are Aging, Biosensors, Cannabis, Cardiovascular Disease, Central Nervous System, Critical Care Medicine, Gastroenterology, Genetics, Infectious Disease, Immunology, Men’s Health, Metabolic Disorders, Microbiome, Neonates & Pediatrics, Neurology, Oncology, Ophthalmology, Opioid Abuse, Orthopedics, Pain, Precision Medicine, Rare Diseases, Radiology, Regenerative Medicine, Respiratory Diseases, Sleep, Women’s Health, and Wound-Healing.

CRS is an approved sub-contractor for the NIH, DoD and DARPA. CRS is affiliated with MTEC and is a Spoke Member of ARPA-H.

CRS requires persons to be authorized to work in the United States and to undergo a background check prior to becoming employed. CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, vaccine status, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.

# # #

Media Contact:
Ron MacDonald
Step2 Branding and Design
ronmac@step2branding.com
+1 724.814.4067

Alethea Wieland, President and Founder
Clinical Research Strategies, LLC
alethea@clinicalresearchstrategies.com
+1 724.272.1245

Download this press release as a PDF.